ARUTYUN TOPSAKALYAN: Open Payments
NPI 1205906310 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 29 payments from 3 companies in 2025. Trend: 2023 $728 · 2024 $471 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $437 |
| ABBVIE INC. | 3 | $75 |
| Novo Nordisk Inc | 2 | $57 |
Products named: OTEZLA, EVENITY, Ozempic, VRAYLAR, REPATHA, UBRELVY.
Industry payments across CA — which companies pay providers there.
